Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase

Nature Structural and Molecular Biology

Volumn 11, Issue 1, 2004, Pages 54-59

  Flinspach, Mack L ^a   Li, Huiying ^a   Jamal, Joumana ^a   Yang, Weiping ^a   Huang, Hui ^b   Hah, Jung Mi ^b   Gómez Vidal, José Antonio ^b   Litzinger, Elizabeth A ^b   Silverman, Richard B ^b   Poulos, Thomas L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CARDIOVASCULAR SYSTEM; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME CONFORMATION; ENZYME INHIBITION; HOST RESISTANCE; HYPOTHESIS; NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN STRUCTURE;

AMIDES; ANIMALS; CATALYTIC DOMAIN; CATTLE; CRYSTALLOGRAPHY, X-RAY; DIPEPTIDES; ELECTROSTATICS; ENZYME INHIBITORS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RATS;

EID: 4444262860     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb704     Document Type: Article

References (36)

1. Moncada, S., Palmer, R.M.J. & Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142 (1991).
2. Dinerman, J.L., Lowenstein, C.J. & Snyder, S.H. Molecular mechanisms of nitric oxide prodiction. Potential relevance to cardiovascular disease. Circ. Res. 73, 217-222 (1993).
3. Kerwin, J.F. Jr., Lancaster, J.R. Jr. & Feldman, P.L. Nitric oxide: A new paradigm for second messengers. J. Med. Chem. 38, 4343-4362 (1995).
4. Salerno, J.C. et al. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J. Biol. Chem. 272, 29769-29777 (1997).
5. Nichida, C.R. & Ortiz de Montellano, P.R. Control of electron transfer in nitric-oxide synthases. J. Biol. Chem. 276, 20116-20124 (2001).
6. 2+/calmodulin-dependent electron transfer. J. Biol. Chem. 274, 30589-30595 (1999).
7. Panda, K., Ghosh, S. & Stuehr, D.J. Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J. Biol. Chem. 276, 23349-23356 (2001).
8. Siddhanta, U. et al. Domain swapping in inducible nitric-oxide synthase. Electron transfer occurs between flavin and heme groups located on adjacent subunits in the dimer. J. Biol. Chem. 273, 18950-18958 (1998).
9. Dawson, V.L. & Dawson, T.M. Nitric oxide in neurodegeneration. Prog. Brain Res. 118, 215-229 (1998).
10. Bingham, C.O. III. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol. Suppl. 65, 3-9 (2002).
11. Cho, C.H. Current roles of nitric oxide in gastrointestinal diorders. J. Physiol. Paris 95, 253-256 (2001).
12. Hobbs, A.J., Higgs, A. & Moncada, S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol. 39, 191-220 (1999).
13. Taddei, S., Virdis, A., Ghiadoni, L., Sudano, I. & Salvetti, A. Endothelial dysfunction in hypertension. J. Cardiovasc. Pharmacol. 38 (suppl. 2), S11-S14 (2001).
14. Sachais, B.S. Platelet-endothelial interactions in atherosclerosis. Curr. Atheroscler. Rep. 3, 412-416 (2001).
15. Rekka, E.A. & Chrysselis, N.C. Nitric oxide in atherosclerosis. Mini Rev. Med. Chem. 2, 433-445 (2002).
16. Crane, B.R. et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279, 2121-2126 (1998).
17. Raman, C.S. et al. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95, 939-950 (1998).
18. Fischmann, T.O. et al. Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nature Struct. Biol. 6, 233-242 (1999).
19. Li, H. et al. The novel binding mode of N-alkyl-N′-hydroxguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. Biochemistry 41, 13868-13875 (2002).
20. Southan, G.J. & Szabo, C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem. Pharmacol. 51, 383-394 (1996).
21. Babu, B.R. & Griffith, O.W. Design of isoform-selective inhibitors of nitric oxide synthase. Curr. Opin. Chem. Biol. 2, 491-500 (1998).
22. Alberton, W.K., Cooper, C. E. & Knowles, R.G. Nitric oxide synthase: structure, function and inhibition. Biochem. J. 357, 593-615 (2001).
23. ω)-nitroarginine-containing dipeptide amides. Potent and highly selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 42, 3147-3153 (1999).
24. Hah, J.-M., Roman, L.J., Martasek, P. & Silverman, R.B. Reduced amide bond peptidomimetica. (4S)-N-(4-amino-5-[aminoalkyl]aminopentyl)-N′ -nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 44, 2667-2670 (2001).
25. Hah, J.-M., Martasek, P., Roman, L.J. & Silverman, R.B. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. J. Med. Chem. 44, 2667-2675 (2003).
26. Raman, C.S. et al. Crystal structure of nitric oxide synthase bound to nitro indazole reveals a novel inactivation mechanism. Biochemistry 40, 13448-13455 (2001).
27. Reif, D.W. & McCreedy, S.A. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch. Biochem. Biophys. 320, 170-176 (1995).
28. Babu, B.R., Frey, C. & Griffith, O.W. L-arginine binding to nitric-oxide synthase. The role of H-bonds to the nonreactive guanidinium nitrogens. J. Biol. Chem. 274, 25218-25226 (1999).
29. Li, H. et al. Mapping the active site polarity in structures of endothelial nitric oxide synthase heme domain complexed with isothioureas. J. Inorg. Biochem. 81, 133-139 (2000).
30. Li, H., Raman, C.S., Martasek, P., Masters, B.S.S. & Poulos, T.L. Crystallographic studies on endothelial nitric oxide synthase complexed with nitric oxide and mechanism-based inhibitors. Biochemistry 40, 5399-5406 (2001).
31. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. & Pease, L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (1989).
32. Gerber, N.C. & Ortiz de Montellano, P.R. Neuronal nitric oxide synthase, expression in Escherichia coli, irreversible inhibition by phenyldiazene, and active site topology. J. Biol. Chem. 270, 17791-17796 (1995).
33. Rodriguez-Crespo, I., Gerber, N.C. & Ortiz de Montellano, P.R. Endothelial nitric-oxide synthase expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J. Biol. Chem. 271, 11462-11467 (1996).
34. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
35. Brunger, A.T. et al. Crystallography & NMR System: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
36. Jones, T.A., Zou, J.-Y., Cowan, S.W. & Kieldgaard, M. Improved methods for building models in electron density and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).